GST-HG141

· Fujian Akeylink Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GST-HG141, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment [Phase 3]

See pricing